Project TitleDetection of Hemoglobin & Glucose for Diabetics
Track Code2016-005
Short Description

The University of Texas at El Paso seeks a partner for licensing a technology for measuring glycated hemoglobin concentration in diabetic and pre-diabetic patients. Glycated hemoglobin typically indicates a three month average plasma glucose concentration.


This novel technology detects the glycated hemoglobin (HgbA1c) and glucose concentration in a blood sample of a patient using a pre-anodized paper printed electrode transducer. Microfluidics and micro-electro-mechanical systems (MEMS) technology enabled the miniaturization of biomedical analysis systems which provide superior performance in analyzing glycated hemoglobin.

Tagsdiabetes, Pre-diabetes, biosensors, biotechnology, glucose monitoring, glycated hemoglobin, microfluidics
Posted DateApr 7, 2016 5:10 PM


XiuJun (James) Li
Gilberto Henao-Pabon


Melissa Silverstein


  • Micro-scale biosystems provide superior performance compared to large-scale systems
  • Highly selective
  • Sensitive and faster
  • Can detect any kind of biological species

Potential Applications

  • Glycated hemoglobin diagnostics
  • Glucose monitoring
  • Microfluidics
  • Biosensors

Contact Information

For more information, please contact UTEP's Office of Technology Commercialization at or 915-747-8030


File Name Description
2016-005 One Pager None Download

Intellectual Property

Patent Number Issue Date Type Country of Filing
None None Other Patent None